Maxim Group Downgrades Brainstorm Cell Therapeutics (BCLI) to Hold Jul 23, 2025 07:19AM
Brainstorm Cell Therapeutics (BCLI) PT Lowered to $10 at Maxim Group Oct 30, 2024 07:58AM
BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit Oct 7, 2024 07:00AM
Brainstorm Cell Therapeutics (BCLI) Prices 11.11M Share Offering at $0.36/sh Jun 27, 2024 09:15AM
BrainStorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering Jun 27, 2024 09:15AM


Jul 17, 2023 09:16AM Brainstorm Cell Therapeutics (BCLI) Announces Pricing of $7.5 Million Registered Direct Offering
Jul 17, 2023 09:15AM Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
Jun 16, 2023 07:00AM BrainStorm Cell Therapeutics to Participate in the Maxim Group Healthcare Virtual Conference
Mar 28, 2022 09:00AM Brainstorm Cell Therapeutics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
Feb 4, 2021 01:25PM Maxim Group Upgrades Brainstorm Cell Therapeutics (BCLI) to Buy
Nov 17, 2020 12:42PM Maxim Group Downgrades Brainstorm Cell Therapeutics (BCLI) to Hold
Jun 7, 2018 08:00AM BrainStorm Announces Exercise of Warrants Resulting in Cash Proceeds of ~$12.3 Million at $5 Share
Mar 30, 2017 09:33AM Brainstorm Cell Therapeutics (BCLI) PT Raised to $8 at Maxim Group
Mar 8, 2017 07:49AM Maxim Group Reiterates Buy Rating and $6 PT on BrainStorm Cell Therapeutics (BCLI) Following New CMO Appointment
Dec 14, 2016 10:48AM Brainstorm Cell Therapeutics (BCLI) Bullish View Reiterated at Maxim Group Following New Data Presentation
Jul 18, 2016 09:07AM Brainstorm Cell (BCLI) ALS Trial Results 'Robust' - Maxim Group
Jun 3, 2016 03:41PM Maxim Positive on BrainStorm Cell Therapeutics (BCLI) into Upcoming NurOwn Phase 2 Data in ALS; Affirms at 'Buy'
Dec 22, 2015 07:17AM Brainstorm Cell Therapeutics (BCLI) PT Cut to $5 at Maxim Group; 'Buy' Maintained
Dec 4, 2015 09:00AM Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report
Aug 11, 2015 11:00AM Brainstorm Cell Therapeutics (BCLI) Completes Nurown Phase 2 Enrollment, Continues Executing Business Plan - Maxim
Apr 21, 2015 08:09AM Brainstorm Cell Therapeutics (BCLI) Bullish Stance Reiterated at Maxim Group Following ALS Study Data
Mar 12, 2015 01:13PM ALS Data Shows Neuralstem (CUR) Approach is 'Risky' - Maxim Group
Jan 20, 2015 08:57AM Brainstorm Cell Therapeutics (BCLI) Bullish Stance Reiterated at Maxim Group Following Capital Raise
Jan 8, 2015 09:46AM Brainstorm Cell Therapeutics (BCLI) Enters 2.5M Common Warrant Exercise Agreement